HCAT - Health Catalyst Inc

HCAT - Health Catalyst Inc

https://www.healthcatalyst.com

Hold Momentum: Bearish

Recent News

Powered by Alpha Vantage

This Deutsche Bank Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday - Krispy Kreme ( NASDAQ:DNUT ) , Deutsche Bank ( NYSE:DB )

Benzinga • 2 weeks, 5 days ago • score: -0.18

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. JP Morgan analyst Rahul Krotthapalli downgraded the rating for Krispy Kreme, Inc.

Health Catalyst ( HCAT ) Q2 Earnings and Revenues Beat Estimates

Zacks Commentary • 1 month, 1 week ago • score: 0.14

Health Catalyst (HCAT) delivered earnings and revenue surprises of +33.33% and +0.24%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Health Catalyst ( HCAT ) Upgraded to Buy: Here's Why

Zacks Commentary • 2 months, 3 weeks ago • score: 0.35

Health Catalyst (HCAT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Health Catalyst ( HCAT ) Q1 Earnings Meet Estimates

Zacks Commentary • 4 months, 1 week ago • score: 0.08

Health Catalyst (HCAT) delivered earnings and revenue surprises of 0% and 0.21%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Hims & Hers Health ( HIMS ) Stock Jumps 23.0%: Will It Continue to Soar?

Zacks Commentary • 4 months, 2 weeks ago

Hims & Hers Health (HIMS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

As of 2025-09-10 (Snapshot)

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. The company is headquartered in South Jordan, Utah.

52W High

$9.24

52W Low

$2.52

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.54

Valuation

Attractive

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

12.08

EV/EBITDA (<8 favorable)

-4.96

EV/Revenue (<3 favorable)

0.99

P/S (TTM) (<3 favorable)

0.75

P/B (<3 favorable)

0.68

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

3.41%

Institutions (25–75% balanced)

79.72%

Shares Outstanding

70,374,000

Float

64,285,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

316,093,000

Gross Profit (TTM)

145,409,000

EPS (TTM)

-1.51

Profit Margin (>10% good)

-0.32%

Operating Margin (TTM) (higher better)

-0.14%

ROE (TTM) (>15% strong)

-0.28%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

0.06

Momentum

Bearish momentum

Value

-0.0359

Previous

-0.0430

Trend

Rising

Signal Cross

No cross

As of

Sep. 05, 2025